The practice of glycemic control with intravenous insulin in critically ill patients has brought clinical focus on understanding the effects of hypoglycemia, especially in children. Very little is published on the impact of hypoglycemia in this population. We aimed to review the existing literature on hypoglycemia in critically ill neonates and children.
Methods:
We performed a systematic review of the literature up to August 2011 using PubMed, Ovid MEDLINE and ISI Web of Science using the search terms “hypoglycemia or hypoglyc*” and “critical care or intensive care or critical illness”. Articles were limited to “all child (0–18 years old)” and “English”.
Results:
A total of 513 articles were identified and 132 were included for review. Hypoglycemia is a significant concern among pediatric and neonatal intensivists. Its Definition is complicated by the use of a biochemical measure (i.e., blood glucose) for a pathophysiologic problem (i.e., neuroglycopenia). Based on associated outcomes, we suggest defining hypoglycemia as <40–45 mg/dl in neonates and <60–65 mg/dl in children. Below the suggested threshold values, hypoglycemia is associated with worse neurological outcomes, increased intensive care unit stay, and increased mortality. Disruptions in carbohydrate metabolism increase the risk of hypoglycemia in critically ill children. Prevention of hypoglycemia, especially in the setting of intravenous insulin use, will be best accomplished by the combination of accurate measuring techniques, frequent or continuous glucose monitoring, and computerized insulin titration protocols.
Conclusion:
Studies on hypoglycemia in critically ill children have focused on spontaneous hypoglycemia. With the current practice of maintaining blood glucose within a narrow range with intravenous insulin, the risk factors and outcomes associated with insulin-induced hypoglycemia should be rigorously studied to prevent hypoglycemia and potentially improve outcomes of critically ill children.
GunstJVan den BergheG. Blood glucose control in the intensive care unit: Benefits and risks. Semin Dial.2010;23 (2): 157–162.
2.
BrancoRGTaskerRC. Outside the limits of normal blood glucose during critical illness: Failed homeostasis and quantifying allostatic load. Pediatr Crit Care Med.2010;11 (6): 755–7.
3.
DellingerRPLevyMMCarletJMBionJParkerMMJaeschkeRReinhartKAngusDCBrun-BuissonCBealeRCalandraTDhainautJFGerlachHHarveyMMariniJJMarshallJRanieriMRamsayGSevranskyJThompsonBTTownsendSVenderJSZimmermanJLVincentJL. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med.2008;34 (1): 17–60.
FaustinoEVBogueCW. Relationship between hypoglycemia and mortality in critically ill children. Pediatr Crit Care Med.2010;11 (6): 690–8.
6.
BrancoR GarciaTaskerRCGarciaPC RamosPivaJPXavierL Dias. Glycemic control and insulin therapy in sepsis and critical illness. J Pediatr (Rio J).2007;83 (5 Suppl): S128–36.
7.
HirshbergELarsenGVan DukerH. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med.2008;9 (4): 361–6.
8.
PreissigCRigbyM. Glycaemic control in paediatric critical care. Lancet2009;373 (9673): 1423.
9.
RigbyMRPreissigCM. Management of hyperglycemia in the pediatric intensive care unit. Pediatr Crit Care Med.2010;11 (1): 163.
10.
VlasselaersDMilantsIDesmetLWoutersPJVanhorebeekIvan den HeuvelIMesottenDCasaerMPMeyfroidtGIngelsCMullerJVan CromphautSSchetzMVan de BergheG. Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet.2009;373 (9663): 547–56.
11.
OgnibeneKLVawdreyDKBiagasKV. The association of age, illness severity, and glycemic status in a pediatric intensive care unit. Pediatr Crit Care Med.2011;12 (6): e386–90.
12.
HirshbergELacroixJSwardKWillsonDMorrisAH. Blood glucose control in critically ill adults and children — A survey on stated practice. Chest.2008;133 (6): 1328–35.
13.
PreissigCMRigbyMR. A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States: A survey on actual practice habits. Crit Care.2010;14 (1): R11.
14.
NayakPLangHParslowRDaviesPMorrisK. Hyperglycemia and insulin therapy in the critically ill child. Pediatr Crit Care Med.2009;10 (3): 303–5.
15.
SalhabWAWyckoffMHLaptookARPerlmanJM. Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia. Pediatrics.2004;114 (2): 361–6.
16.
HilstedJ: Cardiovascular changes during hypoglycaemia. Clin Physiol.1993;13 (1): 1–10.
17.
McCallALFixmanLBFlemingNTornheimKChickWRudermanNB. Chronic hypoglycemia increases brain glucose transport. The Am J Physiol.1986;251 (4 Pt 1): E442–7.
18.
OwenOEMorganAPKempHGSullivanJMHerreraMGCahillGFJr.Brain metabolism during fasting. J Clin Invest.1967;46 (10): 1589–95.
19.
GarberAJKarlIEKipnisDM. Alanine and glutamine synthesis and release from skeletal muscle. I Glycolysis and amino acid release. J Biol Chem.1976;251 (3): 826–35.
20.
KerrDMacDonaldIATattersallRB. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects. J Clin Endocrinol Metab.1989;68 (6): 1118–22.
21.
CryerPE: Glucose counterregulation in man. Diabetes.1981;30 (3): 261–4.
22.
LacheradeJCJacqueminetSPreiserJC. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol.2009;3 (6): 1242–9.
23.
PrammingSThorsteinssonBBendtsonIBinderC. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med.1990;228 (6): 641–6.
24.
PrammingSThorsteinssonBBendtsonIBinderC. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med.1991;8 (3): 217–22.
25.
BhatiaVWolfsdorfJI. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus — Frequency and causative factors. Pediatrics.1991;88 (6): 1187–93.
26.
KohTHAynsley-GreenATarbitMEyreJA. Neural dysfunction during hypoglycaemia. Arch Dis Child.1988;63 (11): 1353–8.
27.
BonacruzGLArnoldJDLeslieGIWyndhamLKoumantakisG. Survey of the Definition and screening of neonatal hypoglycaemia in Australia. J Paediatr Child Health.1996;32 (4): 299–301.
28.
AdamkinDH: Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics.2011;127 (3): 575–9.
BoylePJNagyRJO'ConnorAMKempersSFYeoRAQuallsC. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA.1994;91 (20): 9352–6.
31.
BalionCGreyVIsmailaABlatzSSeidlitzW. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr.2006;6: 28.
32.
BelliniCSerraGRissoDMazzellaMBonioliE. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med.2007;45 (11): 1549–54.
33.
KostGJVuHTLeeJHBourgeoisPKiechleFLMartinCMillerSSOkoroduduAOPodczasyJJWhitlowKJ Webster R. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med.1998;26 (3): 581–90.
34.
TangZLouieRFPayesMChangKCKostGJ. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther.2000;2 (3): 349–62.
35.
McNamaraPJShariefN. Comparison of EML 105 and advantage analysers measuring capillary versus venous whole blood glucose in neonates. Acta Paediatr.2001;90 (9): 1033–41.
36.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med.2005;33 (12): 2778–85.
37.
StenningerEFlinkRErikssonBSahlenC. Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy. Arch Dis Child Fetal Neonatal Ed., 1998;79 (3): F174–9.
38.
WintergerstKABuckinghamBGandrudLWongBJKacheSWilsonDM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics.2006;118 (1): 173–9.
39.
BeardsallKVanhaesebrouckSOgilvy-StuartALVanholeCPalmerCRvan WeissenbruchMMidgleyPThompsonMThioMCornetteLOssuettaIIglesiasITheykensCde JongMAhluwaliaJSde ZegherFDungerDB. Early insulin therapy in very-low-birth-weight infants. N Engl J Med.2008;359 (18): 1873–84.
40.
IshiguroANamaiYItoYM. Managing “healthy” late preterm infants. Pediatr Int.2009;51 (5): 720–5.
PreissigCMHansenIRoerigPLRigbyMR. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit. Pediatric critical care medicine: A journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.2008;9 (6): 581–8.
43.
PreissigCMRigbyMRMaherKO. Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol.2009;30 (8): 1098–104.
44.
Faraon-PogaceanuCBanasiakKJHirshbergELFaustinoEV. Comparison of the effectiveness and safety of two insulin infusion protocols in the management of hyperglycemia in critically ill children. Pediatr Crit Care Med.2010;11 (6): 741–9.
45.
VerhoevenJJBrandJBvan de PolderMMJoostenKFM. Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol. Pediatr Crit Care Med.2009;10 (6): 648–52.
46.
SoghierLMVegaMArefKReinersmanGTKoenigsbergMKoganMBelloJRomanoJHoffmanTBrionLP. Diffuse basal ganglia or thalamus hyperechogenicity in preterm infants. J Perinatol.2006;26 (4): 230–6.
47.
AltmanMVanpeeMCnattingiusSNormanM. Moderately preterm infants and determinants of length of hospital stay. Arch Dis Child Fetal Neonatal Ed.2009;94 (6): F414–8.
48.
NadeemMMurrayDMBoylanGBDempseyEMRyanCA. Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy. BMC Pediatr.2011;11: 10.
MitraAKRahmanMMFuchsGJ. Risk factors and gender differentials for death among children hospitalized with diarrhoea in Bangladesh. J Health Popul Nutr.2000;18 (3): 151–6.
51.
JafarSVan HensbroekMBPalmerASchneiderGGreenwoodB. Predictors of a fatal outcome following childhood cerebral malaria. Am J Trop Med Hyg.1997;57 (1): 20–4.
52.
PolitoAThiagarajanRRLaussenPCGauvreauKAgusMSScheurerMAPigulaFACostelloJM. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation.2008;118 (22): 2235–42.
53.
VlasselaersDMesottenDLangoucheLVanhorebeekIvan den HeuvelIMilantsIWoutersPWoutersPMeynsBBjerreMHansenTKVan de BergheG. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg.2010;90 (1): 22–9.
54.
KyleUGBuJA CossKennedyCEJeffersonLS. Organ dysfunction is associated with hyperglycemia in critically ill children. Intensive Care Med.2010;36 (2): 312–20.
55.
PrammingSThorsteinssonBTheilgaardAPinnerEMBinderC. Cognitive function during hypoglycaemia in type I diabetes mellitus. Br Med J.1986;292 (6521): 647–50.
56.
KalyoncuOAygunCCetinogluEKucukodukS. Neonatal morbidity and mortality of late-preterm babies. J Matern Fetal Neonatal Med.2010;23 (7): 607–12.
57.
LaptookAJacksonGL. Cold stress and hypoglycemia in the late preterm (“near-term”) infant: Impact on nursery of admission. Semin Perinatol.2006;30 (1): 24–7.
58.
MeierPPFurmanLMDegenhardtM. Increased lactation risk for late preterm infants and mothers: Evidence and management strategies to protect breastfeeding. J Midwifery Womens Health.2007;52 (6): 579–87.
59.
MericqV. Prematurity and insulin sensitivity. Horm Res.2006;65Suppl 3: 131–6.
60.
MelamedNKlingerGTenenbaum-GavishKHerscoviciTLinderNHodMYogevY. Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol.2009;114 (2 Pt 1): 253–60.
61.
LouikCMitchellAAEpsteinMFShapiroS. Risk factors for neonatal hyperglycemia associated with 10% dextrose infusion. Am J Dis Child.1985;139 (8): 783–6.
CanpolatFEYurdakokMKorkmazAYigitSTekinalpG. Birthweight discordance in twins and the risk of being heavier for respiratory distress syndrome. Twin Res Hum Genet.2006;9 (5): 659–63.
64.
KilicMAygunCKaynar-TuncelEKucukodukS. Does birth weight discordance in preterm twins affect neonatal outcome?. J Perinatol.2006;26 (5): 268–72.
65.
ZanardoVCagdasSGolinRTrevisanutoDMarzariFRizzoL. Risk factors of hypoglycemia in premature infants. Fetal Diagn Ther.1999;14 (2): 63–7.
66.
AlamMRazaSJSheraliARAkhtarAS. Neonatal complications in infants born to diabetic mothers. J Coll Physicians Surg Pak.2006;16 (3): 212–5.
67.
CarrapatoMRMarcelinoF. The infant of the diabetic mother: The critical developmental windows. Early Pregnancy.2001;5 (1): 57–8.
68.
ChiaYTChuaSThaiACYeohSCKekLPSelamatNRatnamSS. Obstetric outcome of pregestational diabetic pregnancies. Singapore Med J.1995;36 (5): 498–500.
69.
FeinbergJHMagannEFMorrisonJCHolmanJRPolizzottoMJ. Does maternal hypoglycemia during screening glucose assessment identify a pregnancy at-risk for adverse perinatal outcome?. J Perinatol.2005;25 (8): 509–13.
70.
MitanchezD. Management of infants born to mothers with gestational diabetes. Paediatric environment. Diabetes Metab.2010;36 (6 Pt 2): 587–94.
71.
WolfeRR. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. Eur J Clin Nutr.1999;53: S136–S142.
72.
FaustiniAForastiereFRossiP GiorgiPerucciC. An epidemic of gastroenteritis and mild necrotizing enterocolitis in two neonatal units of a University Hospital in Rome, Italy. Epidemiol Infect.2004;132 (3): 455–65.
73.
MugaluJNakakeetoMKKiguliSKaddu-MulindwaDH. Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda. Afr Health Sci.2006;6 (2): 120–6.
74.
DavisDJCreeryWDRadziukJ. Inappropriately high plasma insulin levels in suspected perinatal asphyxia. Acta Paediatr.1999;88 (1): 76–81.
75.
RohatgiMGuptaDKMenonPSNMishraDVermaIC. Nesidioblastosis in infants: Report of 2 cases and review of the literature. Pediatric Surgery International.1991;6 (4–5): 365–7. DOI.10.1007/BF00178659.
76.
WillbergBMullerE: Surgery for nesidioblastosis–indications, treatment and results. Prog Pediatr Surg.1991;26: 76–83.
77.
ShirlandL. When it is more than transient neonatal hypoglycemia: Hyperinsulinemia–a case study challenge. Neonatal Netw.2001;20 (4): 5–11.
78.
PearceJ. Congenital adrenal hyperplasia: A potential diagnosis for the neonate in shock. Aust Crit Care.1995;8 (1): 16–9.
79.
RamadanGIKenneaNL. Beckwith-Wiedemann syndrome associated with congenital hypothyroidism in a preterm neonate: A case report and literature review. J Perinatol.2009;29 (6): 455–7.
80.
BrewsterDR. Critical appraisal of the management of severe malnutrition: 3. Complications. J Paediatr Child Health.2006;42 (10): 583–93.
81.
BennishMLHarrisJRWojtyniakBJStruelensM. Death in shigellosis: Incidence and risk factors in hospitalized patients. J Infect Dis.1990;161 (3): 500–6.
82.
StoutSMCoberMP. Metabolic effects of cyclic parenteral nutrition infusion in adults and children. Nutr Clin Pract.2010;25 (3): 277–81.
83.
BodmanMSmithDNyhanWLNaviauxRK. Medium-chain acyl coenzyme a dehydrogenase deficiency — Occurrence in an infant and his father. Arch Neurol.2001;58 (5): 811–4.
84.
GlasgowJF. Clinical features and prognosis of Reye's syndrome. Arch Dis Child.1984;59 (3): 230–5.
85.
Van WijngaardenROttenBJFestenDAMJoostenKFMde JongFHSweepFHokken-KoelegaACS. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab.2008;93 (5): 1649–54.
86.
GefnerME. Hypopituitarism in childhood. Cancer Control.2002;9 (3): 212–22.
AndreuVMasABrugueraMSalmeronJMMorenoVNogueSRodesJ: Ecstasy. A common cause of severe acute hepatotoxicity. J Hepatol.1998;29 (3): 394–7.
89.
CaravatiEMHeilesonHLJonesM. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol.2004;42 (3): 255–9.
90.
CaverlyLRauschCMda CruzEKaufmanJ. Octreotide treatment of chylothorax in pediatric patients following cardiothoracic surgery. Congenit Heart Dis.2010;5 (6): 573–8.
91.
GreenRPHollanderASThevisMThomasADietzenDJ. Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics.2010;125 (5): e1236–40.
92.
HarveyBHickmanCHinsonGRalphTMayerA. Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. Pediatr Crit Care Med.2005;6 (5): 598–601.
93.
OvaliFSamanciNSevincEDagogluT. Isoniazid and hypoglycaemia in a premature infant. J Paediatr Child Health.2004;40 (8): 490–2.
94.
RefstadS. Paramethoxyamphetamine (PMA) poisoning; a 'party drug' with lethal effects. Acta Anaesthesiol Scand.2003;47 (10): 1298–9.
95.
RoyMBaileyBChalutDSenecalP-EGaudreaultP. What are the adverse effects of ethanol used as an antidote in the treatment of suspected methanol poisoning in children?. J Toxicol — Clin Toxicol.2003;41 (2): 155–61.
96.
HodgettsTJBrettACastleN. The early management of meningococcal disease. J Accid Emerg Med.1998;15 (2): 72–6.
97.
LeclercFNoizetODorkenooACremerRLeteurtreSSadikAFourierC. Treatment of meningococcal purpura fulminans. Arch Pediatr.2001;8: 677S–88S.
98.
AssimadiJKGbadoéADAtakoumaDYAgbénowossiKLawson-EviKGayiborAKassankognoY. Severe malaria in children in Togo. Arch Pediat.1998;5 (12): 1310–5.
99.
IdroRJenkinsNENewtonC. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol.2005;4 (12): 827–40.
100.
KrishnanAKarnadDR. Severe falciparum malaria: An important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med.2003;31 (9): 2278–84.
101.
MishraSKMohantySMohantyADasBS. Management of severe and complicated malaria. J Postgrad Med.2006;52 (4): 281–7.
102.
PasvolG. The treatment of complicated and severe malaria. Br Med Bull.2005;75–6 (1): 29–47.
103.
SerengbeGBNdoyoJGaudeuilleALongoJDDBezzoMEOuilibonaSFAyiviB. An update on severe pediatric malaria in Central Africa hospital units. Med Mal Infect.2004;34 (2): 86–91.
104.
GriesdaleDEde SouzaRJvan DamRMHeylandDKCookDJMalhotraADhaliwalRHendersonWRChittockDRFinferSTalmorD. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ.2009;180 (8): 821–7.
105.
SteilGMLangerMJaegerKAlexanderJGaiesMAgusMS. Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control. Pediat Crit Care Med.2011;12 (6): 643–8.
106.
Screening guidelines for newborns at risk for low blood glucose. Paediatr Child Health.2004;9 (10): 723–40.
107.
BekefiDSzolnokiJKoranyiJFerenczA. Reffectometric blood glucose determination in the neonatological intensive care: Haematocrit dependence. Exp Clin Endocrinol.1984;83 (2): 178–83.
108.
InnanenVTDeLandMEdeCamposFMDunnMS. Point-of-care glucose testing in the neonatal intensive care unit is facilitated by the use of the Ames Glucometer Elite electrochemical glucose meter. J Pediatr.1997;130 (1): 151–5.
109.
MichelAKusterHKrebsAKadowIPaulWNauckMFuschC. Evaluation of the Glucometer Elite XL device for screening for neonatal hypoglycaemia. Eur J Pediatr.2005;164 (11): 660–4.
110.
JuniorSA PulziAssuncaoMSCdMazzaBFFernandesHdSJackiuMFreitasFGRMachadoFR. Accuracy of different methods for blood glucose measurement in critically ill patients. Sao Paulo Med J.2009;127 (5): 259–65.
111.
RosenthalMUgeleBLipowskyGKusterH. The Accutrend sensor glucose analyzer may not be adequate in bedside testing for neonatal hypoglycemia. Eur J Pediatr.2006;165 (2): 99–103.
112.
Roth-KleinerMDiawC StadelmannUrferJRuffieuxCWernerD. Evaluation of different POCT devices for glucose measurement in a clinical neonatal setting. Eur J Pediatr.2010;169 (11): 1387–95.
113.
ZijlstraWGHartNBaarsmaR. The Hemocue B glucose analyser and neonatal blood glucose monitoring. Ann Clin Biochem.1998;35 (Pt 2): 330.
114.
BattelinoTPhillipMBratinaNNimriROskarssonPBolinderJ. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care.2011;34 (4): 795–800.
115.
Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care.2010;33 (1): 17–22.
116.
MesserLRuedyKXingDCoffeyJEnglertKCaswellKIvesB. Educating families on real time continuous glucose monitoring: The DirecNet navigator pilot study experience. Diabetes Educ.2009;35 (1): 124–35.
117.
WeintrobNSchechterABenzaquenHShalitinSLilosPGalatzerAPhillipM. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc. Med2004;158 (7): 677–84.
118.
WeinzimerSMillerKBeckRXingDYFiallo-ScharerRGilliamLKKollmanCLaffelLMaurasNRuedyKTamborlaneWTsalikianE. Effectiveness of continuous glucose monitoring in a clinical care environment evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care.2010;33 (1): 17–22.
119.
WeinzimerSXingDTanseyMFiallo-ScharerRMaurasNWysockiTBeckRTamborlaneWRuedyK. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes.2009;10 (2): 91–6.
120.
BeardsallKOgilvy-StuartALAhluwaliaJThompsonMDungerDB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed.2005;90 (4): F307–10.
121.
BridgesBCPreissigCMMaherKORigbyMR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care.2010;14 (5): R176.
122.
JavidPJHalwickDRBetitPThompsonJELongKZhangYJaksicTAgusMS. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol Ther.2005;7 (3): 431–9.
123.
PiperHGAlexanderJLShuklaAPigulaFCostelloJMLaussenPCJaksicTAgusMS. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics.2006;118 (3): 1176–84.
124.
SteilGMAlexanderJPapasAMonicaLModiBPPiperHJaksicTGottliebRAgusMS. Use of a continuous glucose sensor in an extracorporeal life support circuit. J Diabetes Sci Technol.2011;5 (1): 93–8.
125.
BrancoRGChavanATaskerRC. Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome. Pediatr Crit Care Med.2010;11 (3): 415–9.
126.
HarrisDLBattinMRWestonPJHardingJE. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. J Pediatr.2010;157 (2): 198–202e191.
127.
FortANarsinghaniUBowyerF. Evaluating the safety and efficacy of Glucommander, a computer-based insulin infusion method, in management of diabetic ketoacidosis in children, and comparing its clinical performance with manually titrated insulin infusion. J Pediatr Endocrinol Metab.2009;22 (2): 119–25.
128.
ThompsonBTOrmeJFZhengHLuckettPMTruwitJDWillsonDFHiteR DuncanBrowerRGBernardGRCurleyMASteingrubJSSorensonDKSwardKHirshbergEMorrisAH. Multicenter validation of a computer-based clinical decision support tool for glucose control in adult and pediatric intensive care units. J Diabetes Sci Technol.2008;2 (3): 357–68.
129.
BrancoRGXavierLGarciaPCRPivaJ PFioriHHBaldisserottoMFioriRMTaskerRC. Prospective operationalization and feasibility of a glycemic control protocol in critically ill children. Pediatr Crit Care Med.2011;12 (3): 265–70.
130.
KrikorianAIsmail-BeigiFMoghissiES. Comparisons of different insulin infusion protocols: A review of recent literature. Curr Opin Clin Nutr Metab Care.2010;13 (2): 198–204.
131.
BlahaJKopeckyPMatiasMHovorkaRKunstyrJKotulakTLipsMRubesDStriteskyMSemradM Lindner JHaluzikM. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care.2009;32 (5): 757–61.
132.
LeeAFaddoulBSowanAJohnsonKLSilverKDVaidyaV. Computerisation of a paper-based intravenous insulin protocol reduces errors in a prospective crossover simulated tight glycaemic control study. Intensive Crit Care Nurs.2010;26 (3): 161–8.
